Clinical Trials on Idiopathic Interstitial Pneumonias in Switzerland

Total 188 results

University Hospital, Basel, Switzerland
Kantonsspital Aarau; Kantonsspital Liestal

Completed

Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trial (STEP)

Community-acquired Pneumonia

Switzerland
University Hospital, Basel, Switzerland
greenTEG AG

Completed

Fever Tracking Study

Core Body Temperature in Healthy Subjects | Immune Response to mRNA COVID-19 Vaccination

Switzerland
Insel Gruppe AG, University Hospital Bern
Cystic Fibrosis Foundation; European Cystic Fibrosis Society

Recruiting

COVID-19 Antibody Responses In Cystic Fibrosis (CAR-CF)

Cystic Fibrosis

Switzerland
Salah D. Qanadli
University of Zurich; University of Bern; University of Basel; University of Geneva...

Active, not recruiting

Vascular Abnormalities Detected With Chest CT in COVID-19 (COVID-CAVA)

Pneumonia, Viral | Covid19 | Pulmonary Embolism

Switzerland
Ecole Polytechnique Fédérale de Lausanne
Mindmaze SA

Completed

Virtual Reality Intervention Alleviates Dyspnea in Patients Recovering From COVID Pneumonia

Covid19 | Dyspnea

Switzerland
Prof. Dr. Jörg Leuppi

Terminated

Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS

Covid19 | Corona Virus Infection | ARDS | Aviptadil

Switzerland
Centre Hospitalier Universitaire Vaudois
University of Lausanne

Completed

Health Needs of Patients With Kallmann Syndrome

Kallmann Syndrome | Idiopathic Hypogonadotropic Hypogonadism | Congenital Hypogonadotropic Hypogonadism

Switzerland
Swiss National Fund for Scientific Research
University Hospital, Geneva

Completed

Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia (BICAP)

Community-acquired Pneumonia

Switzerland
University Hospital, Geneva
University Hospital, Basel, Switzerland; Hôpital Fribourgeois; Ospedale Regionale...

Recruiting

Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19

Covid19 | Old Age; Debility | Immuno-Deficiency

Switzerland
Foundation for Innovative New Diagnostics, Switzerland

Completed

COVID-19 Novel Molecular Point of Care Diagnostics Evaluation

COVID-19 Respiratory Infection

Switzerland, Uganda, United Kingdom
University of Zurich

Recruiting

Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome (LungMechCoV-19)

Covid19 | ARDS

Switzerland
Kinarus AG

Suspended

The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2 (KIN-FAST)

COVID-19

Switzerland, Germany
Pediatric Clinical Research Platform
University Hospital, Geneva

Recruiting

Performance and Safety of the Pneumoscope Device in Adults and Children

Pneumonia | Asthma | Respiratory Diseases | Cyanotic Heart Disease

Switzerland
University Hospital, Basel, Switzerland
Swiss Personalized Health Network (SPHN); Personalized Health and Related Technologies...

Terminated

Molecular Biomarkers for Sepsis

Sepsis | Infection, Bacterial | Severe Community-acquired Pneumonia (sCAP)

Switzerland
Calmy Alexandra

Completed

Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland (COPEP)

Prevention of COVID-19

Switzerland, Brazil
University Children's Hospital Basel
Novartis Pharmaceuticals; Stiftung zur Förderung medizinischer und biologischer... and other collaborators

Active, not recruiting

Immunomodulation With Eltrombopag in ITP (iROM2)

Primary Immune Thrombocytopenia (ITP)

Switzerland
University of Zurich
Cantonal Hospital of St. Gallen; Triemli Hospital; Kantonsspital Münsterlingen

Completed

Sevoflurane in COVID-19 ARDS (SevCov)

Coronavirus | ARDS, Human

Switzerland
Novartis Pharmaceuticals
Pediatric Rheumatology International Trials Organization

Completed

Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) (β-SPECIFIC 2)

Systemic Juvenile Idiopathic Arthritis With Active Flare

United States, Argentina, Canada, Switzerland, Germany, Israel, South Africa, Belgium, Italy, Spain, France, Brazil, Turkey, Hungary, Poland, Norway, Sweden, Netherlands, Peru
University Hospital, Basel, Switzerland
University Children's Hospital Basel

Completed

Immunomodulation With Romiplostim in Young Adults With ITP (iROM)

Immune Thrombocytopenia

Switzerland
Swiss Paraplegic Centre Nottwil
Erasmus Medical Center; Rehab Basel; Balgrist University Hospital; Clinique Romande... and other collaborators

Completed

Inspiratory Strength and Respiratory Complications After SCI Injury (RESCOM)

Pneumonia | Spinal Cord Injuries

Switzerland
University Hospital, Basel, Switzerland

Completed

Procalcitonin Guided Antibiotic Therapy and Hospitalisation in Patients With Lower Respiratory Tract Infections: The "ProHOSP" Study

Pneumonia | Bronchitis | Lower Respiratory Tract Infection

Switzerland
University of Lausanne Hospitals

Completed

Physiological Response to Prone Position in COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)

ARDS | Sars-CoV-2 Infection

Switzerland
Actelion

Completed

Open-label Study With Bosentan in Interstitial Lung Disease (BUILD 2 OL)

Interstitial Lung Disease | Scleroderma

United States, Korea, Republic of, Israel, France, United Kingdom, Netherlands, Switzerland, Germany, Canada, Italy, Sweden
University Hospital Inselspital, Berne
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Terminated

CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 (CONVINCE)

COVID-19 | SARS-CoV Infection

Belgium, Switzerland, Italy
Julia Bielicki
University Hospital, Basel, Switzerland; Swiss National Fund for Scientific...

Completed

KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP (KIDS-STEP)

Community-acquired Pneumonia

Switzerland, Germany
MerLion Pharmaceuticals GmbH

Terminated

First Time in Man Trial for Friulimicin B

Staphylococcal Skin Infections | Community Acquired Pneumonia

Switzerland
Prof. Dr. Jörg Leuppi

Completed

High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study (VitCov)

Covid19 | Vitamin D Deficiency | Corona Virus Infection | ARDS | SARS-CoV Infection | Coronavirus

Switzerland
University Hospital Inselspital, Berne

Completed

Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19

COVID-19

Switzerland
Universitaire Ziekenhuizen KU Leuven
University of Zurich; University Hospital, Geneva; University Hospital Carl Gustav... and other collaborators

Recruiting

Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation (DysOSMIC)

Covid19 | Olfactory Dysfunction

Germany, Switzerland, Belgium
ANRS, Emerging Infectious Diseases
University Hospital, Geneva

Recruiting

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial (OPTICOV)

COVID-19 | Immunodeficiency

Switzerland, France
Ottawa Hospital Research Institute
BioMérieux; Centre Hospitalier Régional et Universitaire de Brest

Completed

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism (REVERSEII)

Idiopathic Venous Thromboembolism

United States, Canada, Australia, Belgium, France, India, Switzerland
Cantonal Hospital of St. Gallen
University Hospital Inselspital, Berne; Swiss Federal Institute of Technology

Unknown

Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Diet Supplementation in Pediatric Cystic Fibrosis (MoHuM-1)

Cystic Fibrosis | Microbiota | Pulmonary Inflammation

Switzerland
Boehringer Ingelheim

Recruiting

INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

Lung Diseases, Interstitial

Czechia, Switzerland, Romania, Bulgaria, Poland
University of Zurich
University Hospital, Geneva; University Hospital Inselspital, Berne; University... and other collaborators

Terminated

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

COVID-19 | Pulmonary Embolism, Deep Vein Thrombosis

Switzerland, Germany
University Hospital, Basel, Switzerland
Swiss Multiple Sclerosis Registry

Recruiting

A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort. (MS COVID-19)

Multiple Sclerosis | COVID-19 (Severe Coronavirus Disease 2019)

Switzerland
GeNeuro SA

Completed

Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome

Post-COVID-19 Syndrome

Switzerland, Italy, Spain
University Hospital, Basel, Switzerland
Pharming Technologies B.V.

Terminated

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Coronavirus Infections

Switzerland, Brazil, Mexico
Novartis Pharmaceuticals
International Maternal Pediatric Adolescent AIDS Clinical Trials Group; Southwest...

Terminated

Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA) (β-SPECIFIC 1)

Systemic Juvenile Idiopathic Arthritis

United States, Argentina, Canada, Switzerland, Germany, United Kingdom, Israel, South Africa, Belgium, Greece, Italy, Spain, France, Brazil, Turkey, Hungary, Poland, Norway, Sweden, Netherlands, Peru, Denmark
University Children's Hospital Basel

Completed

Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)

Paediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS)

Switzerland
University Hospital, Basel, Switzerland
Novartis; Swiss National Science Foundation

Completed

Canakinumab in Patients With COVID-19 and Type 2 Diabetes (CanCovDia)

Coronavirus Infection | Diabetes Mellitus, Type 2

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation (NINBOST2018)

Bronchiolitis Obliterans Syndrome (BOS) | Bronchiolitis Obliterans (BO)

Switzerland, Saudi Arabia
Hoffmann-La Roche

Completed

A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United States, Netherlands, Italy, Germany, Switzerland, Czechia, Spain
Celgene

Terminated

Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease

Systemic Sclerosis | Scleroderma, Systemic | Systemic Scleroderma | Interstitial Lung Disease | Sclerosis, Systemic

United States, Spain, France, Australia, Italy, Switzerland, Germany, Poland, United Kingdom, Russian Federation
Novartis Pharmaceuticals
Pediatric Rheumatology International Trials Organization

Completed

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. (β-SPECIFIC 3)

Systemic Juvenile Idiopathic Arthritis

Italy, United States, Belgium, Germany, Greece, Russian Federation, Turkey, Spain, France, Israel, Canada, Hungary, Switzerland, United Kingdom, Brazil, Austria, Sweden, Netherlands, Argentina, Peru, Poland
Prometheus Biosciences, Inc., a subsidiary of Merck...

Recruiting

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) (ATHENA-SSc-ILD)

Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease

United States, Australia, Belgium, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Norway, Poland, Spain, Switzerland, United Kingdom
Anbics Management-Services Ag
Swiss National Science Foundation

Terminated

Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia

Pneumonia, Ventilator-Associated | Pseudomonas Infections

Belgium, Former Serbia and Montenegro, France, Poland, Spain, Switzerland
UCB Pharma

Completed

Transdermal Rotigotine User Surveillance Study (TRUST)

Idiopathic Parkinson Disease

Czechia, Denmark, Germany, Greece, Italy, Mexico, Romania, Slovakia, Spain, Switzerland
Olatec Therapeutics LLC
CTI Clinical Trial and Consulting Services

Terminated

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

Covid19 | Cytokine Release Syndrome

United States, Switzerland
Actelion

Completed

Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis (BUILD 1)

Idiopathic Pulmonary Fibrosis

United States, United Kingdom, Switzerland, Israel, Canada, France, Germany, Italy
European Research Consortium on ITP
Fondazione Progetto Ematologia

Completed

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Primary Immune Thrombocytopenia (ITP)

Spain, Switzerland, United Kingdom, Italy, France, Norway

Clinical Trials on Idiopathic Interstitial Pneumonias in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations